 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This price move could be a signal that TELA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options...

TELA Bio (TELA, $8.1) price may climb as it broke lower Bollinger Band on Sep 20, 2023

This is a signal that TELA's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

TELA Bio (TELA, $8.69) RSI Indicator left the oversold zone on September 18, 2023

MALVERN, Pa., Sept. 18, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions...

TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase

New addition expands reconstruction options for surgeons and patientsMALVERN, Pa., Aug. 16, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company...

TELA Bio Announces U.S. Commercial Launch of OviTex  PRS Long-Term Resorbable for Plastic and Reconstructive Surgery

TELA Bio (TELA, $8.98) RSI Indicator left the oversold zone on August 11, 2023

TELA Bio (TELA, $8.77) RSI Indicator left the oversold zone on August 10, 2023

Analysts have been eager to weigh in on the Healthcare sector with new ratings on TELA Bio (TELA Research Report), GoodRx Holdings (GDRX Resear... Analysts have been eager to weigh in on the Healthcare sector with new ratings on TELA Bio (TELA Research Report), GoodRx Holdings...

Analysts Offer Insights on Healthcare Companies: TELA Bio (TELA), GoodRx Holdings (GDRX) and Mirati Therapeutics (MRTX)

MALVERN, Pa., Aug. 09, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own ...

TELA Bio Reports Second Quarter 2023 Financial Results

MALVERN, Pa., Aug. 04, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the ...

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., July 26, 2023 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the ...

TELA Bio to Announce Second Quarter 2023 Financial Results and Confirms Participation in the Canaccord Genuity 43rd Annual Growth Conference

TELA Bio, Inc. is a commercial stage medical technology company, which focuses on the design, development, and market of tissue reinforcement materials. The company was founded by Antony Koblish and Maarten Persenaire on April 17, 2012 and is headquartered in Malvern, PA.

Watchers	216
52-Wk Low	$6.40
52-Wk High	$13.18

Market Cap	$197.61M
Volume (M)	96,784.00
52-Wk High	$13.18
52-Wk Low	$6.40

TELA TELA Bio Inc

About

Feed

News

Sentiment

Earnings

Fundamentals